A few drugs approved from Phase 2 - Kyprolis -
Post# of 148326
Kyprolis - 10 months after BLA submission, accelerated approval, no priority review
crizotinib - 7 months after BLA submission. accelerated approval, priority review
atezolizumab - 6 months from BLA submission, accelerated approval, priority review
There have been over 30 cancer drugs approved based on Phase 2 data.